Correlation Between Sartorius Stedim and CompuGroup Medical

Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and CompuGroup Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and CompuGroup Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sartorius Stedim Biotech and CompuGroup Medical SE, you can compare the effects of market volatilities on Sartorius Stedim and CompuGroup Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of CompuGroup Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and CompuGroup Medical.

Diversification Opportunities for Sartorius Stedim and CompuGroup Medical

0.12

Correlation Coefficient

Sartorius Stedim  CompuGroup Medical

Average diversification

The 3 months correlation between Sartorius and CompuGroup is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and CompuGroup Medical SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CompuGroup Medical and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with CompuGroup Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CompuGroup Medical has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and CompuGroup Medical go up and down completely randomly.

Pair Corralation between Sartorius Stedim and CompuGroup Medical

Assuming the 90 days trading horizon Sartorius Stedim Biotech is expected to under-perform the CompuGroup Medical. But the stock apears to be less risky and, when comparing its historical volatility, Sartorius Stedim Biotech is 2.65 times less risky than CompuGroup Medical. The stock trades about -0.07 of its potential returns per unit of risk. The CompuGroup Medical SE is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  1,367  in CompuGroup Medical SE on September 23, 2024 and sell it today you would earn a total of  807.00  from holding CompuGroup Medical SE or generate 59.03% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Sartorius Stedim Biotech  vs.  CompuGroup Medical SE

Sartorius Stedim Biotech

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Sartorius Stedim may actually be approaching a critical reversion point that can send shares even higher in January 2025.

CompuGroup Medical

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in CompuGroup Medical SE are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, CompuGroup Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sartorius Stedim and CompuGroup Medical

The main advantage of trading using opposite Sartorius Stedim and CompuGroup Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, CompuGroup Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CompuGroup Medical will offset losses from the drop in CompuGroup Medical's long position.

The idea behind Sartorius Stedim Biotech and CompuGroup Medical SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.